Home Featured Page 268

Featured

Latest

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL)

Cybin Progresses Two Psychedelic Investigational New Drug (“IND”) Candidates and Announces...

Psyched Wellness Submits a Provisional Patent Application For AME-1

Algernon Pharmaceuticals Submits U.S. FDA Pre-IND Meeting Request for Psychedelic Drug...

Optimi Health Receives Health Canada NPN Product Licenses in Preparation for...

World Leading Depression Researcher Dr. Maurizio Fava Joins PharmaTher as Scientific...

Perception Neuroscience And Otsuka Pharmaceutical Announce Collaboration On Development Of PCN-101...

Red Light Holland Successfully Completes Sale and Import of iMicrodose Psychedelic...

PT235 – The Entheo Society of Washington – Dismantling Power Systems...

Pharmadrug Initiates DMT Research Activities via Collaboration with the University of...

Mydecine Innovations Group Provides Update on European Operations

1...267268269...296 Page 268 of 296

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL)

Cybin Progresses Two Psychedelic Investigational New Drug (“IND”) Candidates and Announces...

Psyched Wellness Submits a Provisional Patent Application For AME-1

Algernon Pharmaceuticals Submits U.S. FDA Pre-IND Meeting Request for Psychedelic Drug...

Optimi Health Receives Health Canada NPN Product Licenses in Preparation for...

World Leading Depression Researcher Dr. Maurizio Fava Joins PharmaTher as Scientific...

Perception Neuroscience And Otsuka Pharmaceutical Announce Collaboration On Development Of PCN-101...

Red Light Holland Successfully Completes Sale and Import of iMicrodose Psychedelic...

PT235 – The Entheo Society of Washington – Dismantling Power Systems...

Pharmadrug Initiates DMT Research Activities via Collaboration with the University of...

Mydecine Innovations Group Provides Update on European Operations

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY